740 related articles for article (PubMed ID: 30637548)
1. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
[TBL] [Abstract][Full Text] [Related]
2. FTO expression is associated with the occurrence of gastric cancer and prognosis.
Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH1.
Wang C; Huang Y; Zhang J; Fang Y
Exp Mol Pathol; 2020 Aug; 115():104449. PubMed ID: 32380054
[TBL] [Abstract][Full Text] [Related]
4. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the prognostic and diagnostic values of ALKBH family members in non-small cell lung cancer.
Wang L; Feng X; Jiao Z; Gan J; Meng Q
Pathol Res Pract; 2022 Mar; 231():153809. PubMed ID: 35180653
[TBL] [Abstract][Full Text] [Related]
6. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
[TBL] [Abstract][Full Text] [Related]
7. Novel evidence for m
Shimura T; Kandimalla R; Okugawa Y; Ohi M; Toiyama Y; He C; Goel A
Br J Cancer; 2022 Feb; 126(2):228-237. PubMed ID: 34675398
[TBL] [Abstract][Full Text] [Related]
8. Fat mass and obesity-associated protein (FTO) mediated m
Wu X; Fang Y; Gu Y; Shen H; Xu Y; Xu T; Shi R; Xu D; Zhang J; Leng K; Shu Y; Ma P
Mol Biomed; 2024 Apr; 5(1):11. PubMed ID: 38556586
[TBL] [Abstract][Full Text] [Related]
9. m
Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
[TBL] [Abstract][Full Text] [Related]
10. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
[TBL] [Abstract][Full Text] [Related]
11. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L
BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441
[TBL] [Abstract][Full Text] [Related]
12. Demethyltransferase AlkBH1 substrate diversity and relationship to human diseases.
Zhang Y; Wang C
Mol Biol Rep; 2021 May; 48(5):4747-4756. PubMed ID: 34046849
[TBL] [Abstract][Full Text] [Related]
13. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
14. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
Zheng Q; Yu X; Zhang Q; He Y; Guo W
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779693
[TBL] [Abstract][Full Text] [Related]
15. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
16. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
17. ALKBH1-mediated m
Chen W; Wang H; Mi S; Shao L; Xu Z; Xue M
Mol Oncol; 2023 Feb; 17(2):344-364. PubMed ID: 36550779
[TBL] [Abstract][Full Text] [Related]
18. Gene Alterations of N6-Methyladenosine (m
Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
[TBL] [Abstract][Full Text] [Related]
19. FTO-Dependent
Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
[No Abstract] [Full Text] [Related]
20. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner.
Yin Z; Guo X; Liang X; Wang Z
Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
